Alligator Bioscience Ab Stock Beta
| ATORX Stock | SEK 0.55 0.01 1.85% |
Alligator Bioscience AB fundamentals help investors to digest information that contributes to Alligator Bioscience's financial success or failures. It also enables traders to predict the movement of Alligator Stock. The fundamental analysis module provides a way to measure Alligator Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alligator Bioscience stock.
Alligator |
Alligator Bioscience AB Company Beta Analysis
Alligator Bioscience's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Alligator Bioscience Beta | 1.12 |
Most of Alligator Bioscience's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alligator Bioscience AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Alligator Bioscience AB has a Beta of 1.1231. This is 30.59% higher than that of the Biotechnology sector and 19.2% lower than that of the Health Care industry. The beta for all Sweden stocks is notably lower than that of the firm.
Alligator Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alligator Bioscience's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alligator Bioscience could also be used in its relative valuation, which is a method of valuing Alligator Bioscience by comparing valuation metrics of similar companies.Alligator Bioscience is currently under evaluation in beta category among its peers.
Alligator Bioscience returns are very sensitive to returns on the market. As the market goes up or down, Alligator Bioscience is expected to follow.
Alligator Fundamentals
| Return On Equity | -1.04 | |||
| Return On Asset | -0.48 | |||
| Operating Margin | (5.39) % | |||
| Current Valuation | 236.82 M | |||
| Shares Outstanding | 220.58 M | |||
| Shares Owned By Insiders | 51.92 % | |||
| Shares Owned By Institutions | 11.58 % | |||
| Price To Book | 2.57 X | |||
| Price To Sales | 17.76 X | |||
| Revenue | 12.94 M | |||
| Gross Profit | (111.72 M) | |||
| EBITDA | (130.36 M) | |||
| Net Income | (141.74 M) | |||
| Cash And Equivalents | 278.15 M | |||
| Cash Per Share | 4.27 X | |||
| Total Debt | 3.51 M | |||
| Debt To Equity | 5.10 % | |||
| Current Ratio | 9.65 X | |||
| Book Value Per Share | 0.40 X | |||
| Cash Flow From Operations | (127.03 M) | |||
| Earnings Per Share | (0.60) X | |||
| Target Price | 3.77 | |||
| Number Of Employees | 53 | |||
| Beta | 1.12 | |||
| Market Capitalization | 431.05 M | |||
| Total Asset | 333.2 M | |||
| Z Score | 73.2 | |||
| Net Asset | 333.2 M |
About Alligator Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alligator Bioscience AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alligator Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alligator Bioscience AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alligator Stock Analysis
When running Alligator Bioscience's price analysis, check to measure Alligator Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alligator Bioscience is operating at the current time. Most of Alligator Bioscience's value examination focuses on studying past and present price action to predict the probability of Alligator Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alligator Bioscience's price. Additionally, you may evaluate how the addition of Alligator Bioscience to your portfolios can decrease your overall portfolio volatility.